minocycline hydrochloride

FDA Drug Profile — minocycline hydrochloride, Minocin

minocycline hydrochloride is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including minocycline hydrochloride, Minocin. Available dosage forms: tablet, extended release, injection.

Drug details

Generic Name
minocycline hydrochloride
Brand Names
minocycline hydrochloride, Minocin
Application Number
ANDA203553
Sponsor
Zydus Pharmaceuticals (USA) Inc.
NDC Codes
17
Dosage Forms
TABLET, EXTENDED RELEASE, INJECTION
Routes
ORAL, INTRAVENOUS
Active Ingredients
MINOCYCLINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS & USAGE Minocycline hydrochloride extended-release tablets is indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies ( 14 )]. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated [see Warnings and Precautions ( 5.12 )]. Minocycline hydrochloride extended-release tablets is a tetracycline-class drug indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. ( 1 ) Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria and to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.